Not recruiting
Chronic lymphocytic leukaemia
Not recruitingStudy Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
Registered drugNo placebo
Study Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
Registered drugNo placebo
- Disease:Chronic lymphocytic leukaemia
- Substances:ObinutuzumabVenetoclax+2
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Obinutuzumab
- Sponsor:BeOne Medicines AG



